Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Symptom C2711227|hepatic steatosis
Sentences 14
PubMedID- 20847561 Background: the pathogenic mechanisms of hepatic steatosis in hepatitis c (hcv) remain unclear.
PubMedID- 21054524 Conclusions: amino acid substitutions in the hcv genotype 1b core region are associated with hepatic steatosis in patients with chronic hepatitis c, independent of glucose intolerance.
PubMedID- 24050726 Lipid profile and hepatic steatosis in hepatitis c infected egyptian survivors of childhood cancer.
PubMedID- 21199519 hepatic steatosis in patients with chronic hepatitis c can be due to alcohol consumption and host metabolic factors such as high body mass index (bmi), obesity, hyperlipidemia, metabolic syndrome and diabetes mellitus in which insulin resistance plays an important role.
PubMedID- 21703198 Beneficial il28b genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis c.
PubMedID- 25869759 The frequency of cancer in family was as follows: 18 % in ibd, 9 % in dyspepsia, 28 % in hepatitis c with hepatic steatosis, 21.5 % in hepatitis c without steatosis, and 27 % in nafld (p = 0.006).
PubMedID- 24810965 Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis c virus infection.
PubMedID- 22701799 Insulin resistance or impaired glucose metabolism, is linked to hepatic steatosis in patients with chronic hepatitis c (ch-c).
PubMedID- 24349054 In the near future, transient elastography will be useful for the evaluation of hepatic fibrosis in chronic hepatitis c patients with hepatic steatosis.
PubMedID- 20672387 hepatic steatosis with hepatitis b virus/hepatitis c virus dual infection.
PubMedID- 20931285 Background: hepatic steatosis in hepatitis c virus (hcv)-infected patients has been shown to enhance the progression of liver fibrosis and decrease the response to antiviral therapy.
PubMedID- 20495737 Background: recent findings suggest a higher prevalence of hepatic steatosis in patients with chronic hepatitis c, estimated at 50%.
PubMedID- 20714438 Increasing studies on chronic hepatitis c with hepatic steatosis have been conducted, but little is known about chb with steatosis.
PubMedID- 26214341 Pioglitazone for hepatic steatosis in hiv/hepatitis c virus coinfection.

Page: 1